Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.
D000380:Agranulocytosis / Q000150:complications*; D001424:Bacterial Infections / Q000188:drug therapy*; D002228:Carbenicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002512:Cephalothin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications*; D010406:Penicillins / Q000008:administration & dosage*; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy
D010406:Penicillins; D007612:Kanamycin; D002228:Carbenicillin; D002512:Cephalothin